Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology (Q45743923)

15 December 2017

title

Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology (English)

1 reference

15 December 2017

Simian immunodeficiency virus

main subject

0 references

author name string

Romano JW

1

1 reference

15 December 2017

Shurtliff RN

2

1 reference

15 December 2017

Dobratz E

3

1 reference

15 December 2017

Gibson A

4

1 reference

15 December 2017

Hickman K

5

1 reference

15 December 2017

Markham PD

6

1 reference

15 December 2017

Pal R

7

1 reference

15 December 2017

publication date

1 April 2000

1 reference

15 December 2017

Journal of Virological Methods

published in

1 reference

15 December 2017

volume

86

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

61-70

1 reference

15 December 2017

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Detection of simian immunodeficiency virus RNA from infected rhesus macaques by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Rapid and simple method for purification of nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Workin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Coinfection of macaques with simian immunodeficiency virus and simian T cell leukemia virus type I: effects on virus burdens and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

The use of the polymerase chain reaction for the detection of Simian immunodeficiency virus in experimentally infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Detection of HIV-1 infection in vitro using NASBA: an isothermal RNA amplification technique

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

HIV viral load markers in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

Constructing DNA by polymerase recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900184-6

7 January 2021

10.1016/S0166-0934(99)00184-6

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017